Cargando…

Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases

Detalles Bibliográficos
Autores principales:	Canna, SW, de Jesus, AA, Shi, G, Huang, Y, Sanchez, GA Montealegre, Gery, I, Goldbach-Mansky, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597293/ http://dx.doi.org/10.1186/1546-0096-13-S1-P10

Ejemplares similares

Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN
por: Mendonca, LO, et al.
Publicado: (2015)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Recurrent Inflammatory Panniculitis with Partial Lipoatrophy and Elevated temperature: a possible new autoinflammatory disorder
por: Torrelo, A, et al.
Publicado: (2015)

Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18
por: Alehashemi, Sara, et al.
Publicado: (2020)

Editorial: Insights in autoimmune and autoinflammatory disorders: 2021
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2022)

Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
por: de Jesus, A Almeida, et al.
Publicado: (2015)

A de novo nonsense mutation in the tyrosine kinase lyn in a patient with an early onset autoinflammatory phenotype
por: De Jesus, Adriana Almeida, et al.
Publicado: (2014)

IL-10 is a critical negative regulator of macrophage activation syndrome
por: Canna, Scott, et al.
Publicado: (2012)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

Recommendations for the management of autoinflammatory diseases
por: ter Haar, N, et al.
Publicado: (2015)

Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases
por: Alehashemi, Sara, et al.
Publicado: (2022)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

IL-1 blockade as a novel approach to treatment of hyperzincemia and hypercalprotectinemia, a possible new autoinflammatory syndrome
por: Lionetti, Geraldina, et al.
Publicado: (2012)

Therapy of autoinflammatory diseases: a review of the literature
por: ter Haar, NM, et al.
Publicado: (2011)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
por: Fernandez-Silveira, Laura, et al.
Publicado: (2014)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

NLRP12- associated autoinflammatory disorder: case report
por: Volpe, Giuseppina, et al.
Publicado: (2014)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

Use of TNF inhibitors in the treatment of PAPA syndrome
por: Stone, D, et al.
Publicado: (2015)

A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
por: Barut, K, et al.
Publicado: (2015)

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
por: Zulian, F, et al.
Publicado: (2011)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
por: Baggio, Chiara, et al.
Publicado: (2023)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Determinants of health-related quality of life in children and adults with autoinflammatory diseases
por: Erbis, G, et al.
Publicado: (2015)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, D, et al.
Publicado: (2015)

Studying patients with autoinflammatory diseases: the past, present, and a perspective for the future
por: Hausmann, JS, et al.
Publicado: (2015)

Monogenetic autoinflammatory syndromes and nephrology - therapy is usefull even in advanced kidney failure
por: Hohenstein-Scheibenecker, K, et al.
Publicado: (2015)

Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
por: Topaloglu, R, et al.
Publicado: (2015)

Implementation of home measurement of CRP levels in diagnosis and monitoring of children with autoinflammatory diseases
por: Wolska-Kuśnierz, B, et al.
Publicado: (2015)

STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children
por: Eroglu, F Kara, et al.
Publicado: (2015)

Diagnosis of NLRP3 somatic mosaicism in CINCA/NOMID patients using next-generation sequencing
por: Izawa, K, et al.
Publicado: (2011)

Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?
por: Lamot, L, et al.
Publicado: (2011)

PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina
por: Russo, RA, et al.
Publicado: (2013)

Monogenic and multifactorial autoinflammatory diseases: Clinical and laboratory characterization in a pediatric Saudi population
por: Al-Mayouf, S, et al.
Publicado: (2015)

Single center experience in Next Generation Sequencing for genetic diagnosis of Autoinflammatory Disorders (AIDs)
por: Lepri, FR, et al.
Publicado: (2015)

A heterozygous variant in MEFV in a familial autoinflammatory syndrome with PAPA-like features
por: Jéru, I, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ealar2oqnf9lv4c61bpe3v3li8